This is a link which rarely exists in construction, where there are typically numerous tiers between the client and manufacturers, introducing enormous economic ‘friction’ and transactional cost.
The people in leadership positions, whose jobs aren’t vulnerable, they’re the ones who need to move this forward.“You've got to think about the long game,” Marks says, “and whether or not you're going to exist on this planet.”.
She’s also aware that there’s a monetary opportunity here, on top of the current $14 trillion industry ecosystem.The projection is that the industry will make a 45% shift to industrialised construction.Companies that do this well will increase their value, but changes will be necessary.
For a start, technology spending will double.. We’ll also need to have a complete understanding of how the traditional and industrialised aspects of a building will interact with each other, she says.. “You're talking about interstitial spaces, adjacencies, attachments, components.You need to know it for everything,” Marks says..
Looking toward the future: sustainability in construction.
Still, the reality is that the construction industry has been in a state of poor productivity and other difficulties for decades, so why is it that we finally appear to be standing on the cusp of an industrialised construction transformation?.Working alongside local stakeholders to ensure the viability of delivery in Italy, we overlapped design, procurement and construction activities to prioritise elements of the build according to variables like complexity and long-lead-time equipment..
Rigorous interrogation of the design at each stage helped ensure construction and commissioning was completed on budget and within a very tight schedule: 15 months from groundbreaking to handover of the fully finished facility..The project was one of two FOYA Category Winners for Social Impact in 2020.
“The team paid attention to creating a ‘can do’ attitude and culture whilst implementing accelerated delivery tools,” said the FOYA Judging Panel.“As a result, GSK and ViiV Healthcare ensured the continuity of supply of Fostemsavir for clinical trials.”.
(Editor: Mini Dash Cams)